Skeletal muscle dysfunction in lung transplantation

Journal of Heart and Lung Transplantation

Volumn 19, Issue 4, 2000, Pages 392-400

  Krieger, Ana C ^a   Szidon, Peter ^a   Kesten, Steven ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CYCLOSPORIN; INOSINE PHOSPHATE;

CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXERCISE; HUMAN; LUNG TRANSPLANTATION; MUSCLE BLOOD FLOW; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE METABOLISM; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

EID: 0034128847     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00065-6     Document Type: Article

References (61)

1. Lands LC, Smountas AA, Messiano J, et al. Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. Am Rev Respir Crit Care Med 1995;A523.
2. Myioshi S., Trulock E.P., Schaefers H., Hsieh C., Patterson G.A., Cooper J.D. Cardiopulmonary exercise testing after single and double lung transplantation. Chest. 97:1990;1130-1136.
3. Schwaiblmair M, Dienemann H, Kolbe T, Vogelmeier C, Reichart B and Munich Lung Transplant Group. Cardiopulmonary exercise responses before and after lung transplantation. Am Rev Respir Crit Care Med 1996;A828.
4. Jakobsson P., Jorfeldt L., Brundin A. Skeletal muscle metabolites and fiber type in patients with advanced chronic obstructive pulmonary disease with and without chronic respiratory failure. Eur Resp J. 3:1990;192-196.
5. Guyton A.C. Sports Physiology. Guyton A.C., Hall J.E. Textbook of Medical Physiology. 1996;1059-1069 WB Saunders, Philadelphia, Pa.
6. Stratton J.R., Kemp G.J., Daly R.C., Yacoub M., Rajagoplan B. Effects of cardiac transplantation on bioenergetic abnormalities of skeletal muscle in congestive heart failure. Circulation. 89:1994;1624-1631.
7. 2max. J Appl Physiol. 73:(3):1992;1067-1076.
8. Murphy R. Skeletal muscle physiology. Berne R.M., Levy M.N. Physiology. 1998;282-299 Mosby, New York, NY.
9. Chi MMY, Hintz CS, Coyle EF, et al. Effects of detraining on enzymes of energy metabolism individual human muscle fibers. Am J Physiol 1983;244:C276-87.
10. Larsson L., Ansved T. Effects of long-term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristics in man. Muscle Nerve. 8:1985;714-722.
11. Appell H.J. Muscular atrophy following immobilisation. Sports Medicine. 10:(1):1990;42-58.
12. Rutherford O.M., Jones D.A., Rond J.M. Long-lasting unilateral muscle wasting and weakness following injury and immobilisation. Scan J Rehab Med. 22:1990;33-37.
13. Proctor D.N., Sinning W.E., Walro J.M., Sieck G.C., Lemon P.W.R. Oxidative capacity of human muscle fiber type effects of age and training status . J Appl Physiol. 78:1995;2033-2038.
14. Coggan A.R., Spina R.J., King O.S., et al. Histochemical and enzymatic comparison of the gasrocnemius muscle of young and elderly men and women. J Gerontol. 47:1992;B71-B76.
15. Coggan A.R., Abduljalil A.M., Swanson S.C., et al. Muscle metabolism during exercise in young and older untrained and endurance-trained men. J Appl Physiol. 75:1993;2125-2133.
16. Meredith C.N., Frontera W.R., Fisher E.C., et al. Peripheral effects of endurance training in young and old subjects. J Appl Physiol. 66:1989;2844-2849.
17. Gosselink R., Troosters T., Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 153:1996;976-980.
18. Killian K.J., Leblanc P., Martin D.H., Summers E., Jones N.L., Campbell E.J.M. Exercise capacity and ventilatory, circulatory and symptoms limitation in patients with chronic airflow limitation. Am Rev Respir Dis. 146:1992;935-940.
19. Gallagher C.G. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin Chest Med. 15:(2):1994;305-326.
20. Allard C., Jones N.L., Killian K.J. Static peripheral skeletal muscle strength and exercise capacity in patients with chronic airflow obstruction. (abstract) Am Rev Respir Dis. 139:1989;A90.
21. Maltais F., Jobin J., Sullivan M.J., et al. Metabolic and hemodynamic responses of lower limb exercise in patients with COPD. J Appl Physiol. 84:1998;1573-1580.
22. Bernard S., LeBlanc P., Whittom F., et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 158:1998;629-634.
23. Maltais F., Simard A., Simard C., Jobin J., Desgagnes P., LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 153:1996;288-293.
24. Pouw E.M., Schols A.M.W.J., Van Der Vusse G.J., Wouters E.F.M. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 157:1998;453-457.
25. Lands L.C., Heigenhauser G.J.F., Jones N.L. Analysis of factors limiting maximal exercise performance in cystic fibrosis. Clin Scien. 83:1992;391-397.
26. Hughes R.L., Katz H., Sahgal V., Campbell J.A., Hartz R., Shields T.W. Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung disease. Respiration. 44:1983;321-328.
27. Kutsuzawa T., Shioya S., Kurita D., Haida M., Ohta Y., Yamabayashi H. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 152:1995;647-652.
28. Kutsuzawa T., Shioya S., Kurita D., Haida M., Ohta Y., Yamabayashi H. P31 NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. Am Rev Respir Dis. 146:1992;1019-1024.
29. Fiaccadori E., Del Canali S., Vitali P., Coffrini E., Ronda N., Guariglia A. Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. Chest. 92:1987;883-887.
30. Gertz I., Hendenstierna G., Hellers Wahren J. Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure. Clin Sci Mol Med. 52:1977;395-403.
31. Sala E., Roca J., Marrades R.M., et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 159:1999;1726-1734.
32. Richardson R.S., Sheldon J., Poole D.C., Hopkins S.R., Ries A.L., Wagner P.D. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 159:1999;881-885.
33. Wagner P.D. Determinants of maximal oxygen transport and utilization. Annu Rev Physiol. 58:1996;21-50.
34. Wagner P.D. Muscle O2 transport and O2 dependent control of metabolism. Med Sci Sports Exerc. 27:1995;47-53.
35. Johnson P.C., Wagner P.D., Wilson D.F. Regulation of oxidative metabolism and blood flow in skeletal muscle. Med Sci Sports Exerc. 28:(3):1996;305-314.
36. Systrom D.M., Pappagianopoulus P., Fishman R.S., Wain J.C., Ginns L.C. Determinants of abnormal maximum oxygen uptake after lung transplantation for chronic obstructive pulmonary disease. J Heart Lung Transplant. 17:1998;1220-1230.
37. Levine S.M., Anzueto A., Peters J.I., et al. Medium term functional results of single lung transplantation for endstage obstructive lung disease. Am J Respir Crit Care Med. 150:1994;398-402.
38. Williams T.J., Grossman R.F., Maurer J.R. Long-term functional follow-up of lung transplant recipients. Clin Chest Med. 11:1990;347-358.
39. Lands LC, Mesiano G, Hornby L, Shennib H. Exercise limitation and peripheral skeletal muscle function following lung transplantation. Am Rev Respir Crit Care Med 1996;A828.
40. Ambrosino N., Bruschi D., Callegari G., et al. Time course of exercise capacity, skeletal and respiratory muscle performance after heart-lung transplantation. Eur Respir J. 9:1996;1508-1514.
41. Williams T.J., Patterson G.A., McClean P.A., Zamel N., Maurer J.R. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis. 145:1992;101-105.
42. Ross D.J., Waters P.F., Mohsenifar Z., Belman M.J., Kass R.M., Koerner S.K. Hemodynamic responses to exercise after lung transplantation. Chest. 103:1993;46-53.
43. Evans A.B., Al-Himyary A.J., Hrovat M.I., et al. Abnormal skeletal muscle oxidative capacity after lung transplantation by P-MRS. Am J Respir Crit Care Med. 155:1997;615-621.
44. Fujii T., Kurihara N., Fujimoto S., Hirata K., Yoshikawa J. Role of pulmonary vascular disorder in determining exercise capacity in patients with severe chronic pulmonary disease. Clin Physiol. 16:1996;521-533.
45. Hogan M., Nioka S., Brechue W., Chance B. A P31 NMR study of tissue respiration in working dog muscle during reduced O2 delivery conditions. J Appl Physiol. 73:1992;1662-1670.
46. Rexroth W., Semmlre W., Guckel F., et al. Assessment of muscular metabolism in peripheral arterial occlusive disease using P31 nuclear magnetic resonance spectroscopy. Klin Worchenschr. 67:1989;804-812.
47. Thompson C.H., Kemp G.J., Taylor D.J., Radda G.K., Rajagopalan B. No evidence of mitochondrial abnormality in skeletal muscle of patients with iron-deficient anemia. J Int Med. 234:1993;149-154.
48. Wang X.N., Williams T.J., McKenna M.J., et al. Skeletal muscle oxidative capacity, fiber type and metabolites after lung transplantation. Am J Respir Crit Care Med. 160:1999;57-63.
49. Oelberg D.A., Systrom D.M., Markowitz D.H., et al. Exercise performance in cystic fibrosis before and after bilateral lung transplantation. J Heart Lung Transplant. 17:1998;1104-1112.
50. Linderholm H., Muller R., Ringqvist T., Sornas R. Hereditary abnormal muscle metabolism with hyperkinetic circulation during exercise. Acta Med Scand. 185:1969;153-166.
51. Tirdel G.B., Girgis R., Fishman R., Theodore J. Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients. J Heart Lung Transplant. 17:1998;1231-1237.
52. Lindinger M.I., Sjogaard G. Potassium regulation during exercise and recovery. Sports Med. 11:1991;382-401.
53. Hall M.J., Snell G.I., Side E.A., Esmore D.S., Walters E.H., Williams T.J. Exercise, potassium and muscle deconditioning. J Appl Physiol. 77:(6):1994;2784-2790.
54. Williams TJ, Fraser SF, McKenna MJ, et al. Skeletal muscle sodium/potassium pump activity is normal post lung transplantation. Am Rev Respir Crit Care Med 1996;A828.
55. Bussieres L.M., Pfugfelder P.W., Taylor A.W., Noble E.G., Kostuk W.J. Changes in skeletal muscle morphology and biochemistry after cardiac transplantation. Am J Cardiol. 78:1997;630-634.
56. Lampert E., Mettauer B., Hoppeler H., Charloux A., Charpentier A., Lonsdorfer J. Structure of skeletal muscle in heart transplant recipients. J Am Coll Cardiol. 28:1996;980-984.
57. Jensen R.L., Yanowitz F.G., Crapo R.O. Exercise hemodynamics and oxygen delivery measurements using rebreathing techniques in heart transplant patients. Am J Cardiol. 68:1991;129-133.
58. Robertson H.T., Haley N.R., Guthrie M., Cadenas D., Eschbach J.W., Adamson J.W. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am J Kidney Dis. 15:1990;325-332.
59. Hokanson J.F., Mercier J.G., Brooks G.A. Cyclosporin A decreases rat skeletal muscle mytochondrial respiration in vitro. Am J Respir Crit Care Med. 151:1995;1848-1851.
60. Mercier J.G., Hokanson J.F., Brooks G.A. Effects of cyclosporin A on skeletal muscle mytochondrial respiration and endurance time in rats. Am J Respir Crit Care Med. 151:1995;1532-1536.
61. Biring M.S., Fournier M., Ross D.J., Lewis M.I. Cellular adaptations of skeletal muscles to cyclosporin. J Appl Physiol. 84:1998;1967-1975.